| FKTOX | FOITX | FKTOX / FOITX | |
| Total Expense Ratio | 0.53 | 1.20 | 44% |
| Annual Report Gross Expense Ratio | 0.53 | 1.20 | 44% |
| Fund Existence | 9 years | 31 years | - |
| Gain YTD | 1.807 | 1.493 | 121% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 899M | 899M | 100% |
| Annual Yield % from dividends | 3.62 | 2.90 | 125% |
| Returns for 1 year | 7.49 | 6.75 | 111% |
| Returns for 3 years | 12.31 | 9.96 | 124% |
| Returns for 5 years | -0.97 | -3.74 | 26% |
| Returns for 10 years | N/A | 0.21 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MPL | 17.39 | 0.27 | +1.57% |
| Defiance Daily Target 2X Long MP ETF | |||
| NOCT | 62.02 | 0.17 | +0.27% |
| Innovator Growth-100 Pwr Buff ETF™ Oct | |||
| SEPT | 37.24 | 0.10 | +0.27% |
| AllianzIM US Equity Buffer10 Sep ETF | |||
| CGGE | 34.21 | 0.08 | +0.23% |
| Capital Group Global Equity ETF | |||
| ARKG | 33.47 | -0.18 | -0.53% |
| ARK Genomic Revolution ETF | |||